Short Seller Scores Big Win as Tiny Biotech Stock Sinks 72%

(Bloomberg) -- Short-seller Joseph Lawler’s bearish call on AnaptysBio Inc. scored a huge pay-day after the company’s experimental drug, etokimab, failed to meet its goals in an eczema study. The s...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.